Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature.

Katsura Kakoki, Yasuyoshi Miyata, Yasushi Mochizuki, Takahisa Iwata, Masayuki Obatake, Kuniko Abe, Takeshi Nagayasu, Hideki Sakai

Journal: Clinical genitourinary cancer 2018;15(3):e503-e506

PMID: 28190703

Full Text on Elsevier Science View on PubMed

Abstract

Address: Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Electronic address: [email protected].; Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Surgery, Kochi Medical School, Kochi, Japan.; Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan.; Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

DOI: 10.1016/j.clgc.2016.12.026

Link outs

Free resources

Medical:

https://medlineplus.gov/kidneycancer.html

Other Literature Sources:

https://scite.ai/reports/28190703

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Age of Onset, Antineoplastic Agents, Axitinib, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Carcinoma, Renal Cell, Catheter Ablation, Child, Combined Modality Therapy, Everolimus, Fatal Outcome, Humans, Imidazoles, Indazoles, Indoles, Kidney Neoplasms, Male, Molecular Targeted Therapy, Niacinamide, Oncogene Fusion, Phenylurea Compounds, Pyrroles, Sorafenib, Sunitinib, Translocation, Genetic, Young Adult